Blood Cancer Journal (Jan 2021)
All-trans retinoic acid 45 mg/m2 is superior to 25 mg/m2 as the first induction regimen for the treatment of acute promyelocytic leukaemia: a retrospective analysis in a real-world clinical setting
- Xinhui Zhang,
- Shanglong Feng,
- Jin Xu,
- Na Zhao,
- Xing Hu,
- Li Zhou,
- Juan Tong,
- Lei Xue,
- Lei Zhang,
- Yongsheng Han,
- Xingbing Wang,
- Liangquan Geng,
- Xiaoyu Zhu,
- Baolin Tang,
- Huilan Liu,
- Weibo Zhu,
- Xiaoyan Cai,
- Xin Liu,
- Zimin Sun,
- Changcheng Zheng
Affiliations
- Xinhui Zhang
- Department of Hematology, Anhui Provincial Hospital, Anhui Medical University
- Shanglong Feng
- Department of Hematology, Anhui Provincial Hospital, Anhui Medical University
- Jin Xu
- Wannan Medical College
- Na Zhao
- Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
- Xing Hu
- Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
- Li Zhou
- Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
- Juan Tong
- Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
- Lei Xue
- Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
- Lei Zhang
- Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
- Yongsheng Han
- Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
- Xingbing Wang
- Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
- Liangquan Geng
- Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
- Xiaoyu Zhu
- Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
- Baolin Tang
- Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
- Huilan Liu
- Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
- Weibo Zhu
- Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
- Xiaoyan Cai
- Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
- Xin Liu
- Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
- Zimin Sun
- Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
- Changcheng Zheng
- Department of Hematology, Anhui Provincial Hospital, Anhui Medical University
- DOI
- https://doi.org/10.1038/s41408-021-00411-9
- Journal volume & issue
-
Vol. 11,
no. 1
pp. 1 – 5
Abstract
No abstracts available.
